Clinical Trial Results:
A randomized, open-label, multi-center, phase II/III study on treatment with ABR-217620 combined with IFN-α vs. IFN-α alone in patients with advanced renal cell carcinoma
Summary
|
|
EudraCT number |
2006-004956-19 |
Trial protocol |
BG GB |
Global completion date |
19 Oct 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Mar 2016
|
First version publication date |
04 Mar 2016
|
Other versions |
|
Summary report(s) |
A randomized, open-label, multi-center, phase II/III study on treatment with ABR-217620 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.